Teva Pharmaceuticals USA Inc Recall: Montelukast Sodium Oral Granules USP, 4 mg, packaged
Teva Pharmaceuticals USA Inc Recall: Montelukast Sodium Oral Granules USP, 4 mg, packaged is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA Inc; Product: Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed
| Recalling firm | Teva Pharmaceuticals USA Inc |
|---|---|
| Product | Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19 |
| Reason for recall | Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | USA Nationwide |
| Recall initiated | 20230327 |
| Recall number | D-0510-2023 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →